Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)
Saved in:
Main Authors: | Hirani SP (Author), Kassoumeri L (Author), Mulligan K (Author), Ruperto N (Author), Woo P (Author), Wedderburn LR (Author), Newman SP (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2008-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)
by: Hirani SP, et al.
Published: (2008) -
Can inflammatory markers predict response to methotrexate in JIA? Results from the CHARM study
by: Roth J, et al.
Published: (2011) -
Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate
by: Patrick F, et al.
Published: (2011) -
Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
by: Wulffraat NM, et al.
Published: (2011) -
Contradictory and weak evidence on the effectiveness of anti-emetics for MTX-intolerance in JIA-patients
by: Casper G. Schoemaker, et al.
Published: (2018)